Author/Authors :
Ebrahim Valojerdi, Ameneh Department of Biostatistics - School of Public Health - Iran University of Medical Sciences, Tehran, Iran , Tanha, Kiarash Department of Biostatistics - School of Public Health - Iran University of Medical Sciences, Tehran, Iran , Janani, Leila Department of Biostatistics - School of Public Health - Iran University of Medical Sciences, Tehran, Iran
Abstract :
Background: The calculation of the sample size is one of the most important steps in designing a randomized controlled trial. The
purpose of this study is drawing the attention of researchers to the importance of calculating and reporting the sample size in randomized
controlled trials.
Methods: We reviewed related literature and guidelines and discussed some important issues in sample size calculation and reporting
in randomized controlled trials.
Conclusion: The calculation of the sample size is one of the most important steps in designing a randomized controlled trial. According
to the CONSORT (Consolidated Standards of Reporting Trials) guideline and other standard guidelines for designing and
reporting of RCTs, sample size calculations should be reported and justified in all published RCTs. Because sample size calculations
are prone to bias and because of the high ethical and financial costs related to conducting an RCT, we recommend involving a biostatistician
at the designing stage of the study and to ask for statistical advice for sample size calculations.